{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:21:14Z","timestamp":1792264874201,"version":"4.4.0"},"reference-count":152,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Cachexia is a condition characterized by substantial loss of body weight resulting from the depletion of skeletal muscle and adipose tissue. A considerable fraction of patients with advanced cancer, particularly those who have been diagnosed with pancreatic or gastric cancer, lung cancer, prostate cancer, colon cancer, breast cancer, or leukemias, are impacted by this condition. This syndrome manifests at all stages of cancer and is associated with an unfavorable prognosis. It heightens the susceptibility to surgical complications, chemotherapy toxicity, functional impairments, breathing difficulties, and fatigue. The early detection of patients with cancer cachexia has the potential to enhance both their quality of life and overall survival rates. Regarding this matter, blood biomarkers, although helpful, possess certain limitations and do not exhibit universal application. Additionally, the available treatment options for cachexia are currently limited, and there is a lack of comprehensive understanding of the underlying molecular pathways associated with this condition. Thus, this review aims to provide an overview of molecular mechanisms associated with cachexia and potential therapeutic targets for the development of effective treatments for this devastating condition.<\/jats:p>","DOI":"10.3390\/cells13030252","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T12:25:01Z","timestamp":1706531101000},"page":"252","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Molecular Mechanisms of Cachexia: A Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-3753","authenticated-orcid":false,"given":"Mahdi","family":"Neshan","sequence":"first","affiliation":[{"name":"Department of General Surgery, Shahid Sadoughi University of Medical Sciences and Health Services, Yazd 8915887857, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamantis I.","family":"Tsilimigras","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0238-543X","authenticated-orcid":false,"given":"Xu","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-7326","authenticated-orcid":false,"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7994-9870","authenticated-orcid":false,"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: An international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_2","first-page":"181","article-title":"Cancer cachexia and immunomodulation","volume":"10","author":"Myrianthefs","year":"2005","journal-title":"J. BUON"},{"key":"ref_3","first-page":"9","article-title":"Inter-tissue communication in cancer cachexia","volume":"15","author":"Stemmler","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: Understanding the molecular basis","volume":"14","author":"Busquets","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Freire, P.P., Fernandez, G.J., Cury, S.S., de Moraes, D., Oliveira, J.S., de Oliveira, G., Dal-Pai-Silva, M., Dos Reis, P.P., and Carvalho, R.F. (2019). The Pathway to Cancer Cachexia: MicroRNA-Regulated Networks in Muscle Wasting Based on Integrative Meta-Analysis. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081962"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","article-title":"Symptom prevalence in patients with incurable cancer: A systematic review","volume":"34","author":"Teunissen","year":"2007","journal-title":"J. Pain Symptom Manag."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jcsm.13116","article-title":"The atypical \u03b2-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model","volume":"14","author":"Yuan","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/jcsm.13222","article-title":"A novel orthotopic mouse model replicates human lung cancer cachexia","volume":"14","author":"Theys","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: Mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","article-title":"Cancer Cachexia: Beyond Weight Loss","volume":"12","author":"Bruggeman","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tao, W., Ouyang, Z., Liao, Z., Li, L., Zhang, Y., Gao, J., Ma, L., and Yu, S. (2023). Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1. Cancers, 15.","DOI":"10.3390\/cancers15082378"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clnu.2011.07.010","article-title":"Is IL-6 the best pro-inflammatory biomarker of clinical outcomes of cancer cachexia?","volume":"31","author":"Watt","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/jcsm.12077","article-title":"MAP3K11\/GDF15 axis is a critical driver of cancer cachexia","volume":"7","author":"Lerner","year":"2016","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jcsm.12675","article-title":"The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: Facts and numbers","volume":"12","author":"Wakabayashi","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/15353702221087962","article-title":"Tumor cell anabolism and host tissue catabolism-energetic inefficiency during cancer cachexia","volume":"247","author":"Hegde","year":"2022","journal-title":"Exp. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hed.23696","article-title":"Cancer cachexia update in head and neck cancer: Pathophysiology and treatment","volume":"37","author":"Couch","year":"2015","journal-title":"Head. Neck"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MCO.0b013e328339fdd2","article-title":"Pathogenesis of muscle wasting in cancer cachexia: Targeted anabolic and anticatabolic therapies","volume":"13","author":"Burckart","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"971295","DOI":"10.3389\/fpain.2022.971295","article-title":"Cancer cachexia: Pathophysiology and association with cancer-related pain","volume":"3","author":"Law","year":"2022","journal-title":"Front. Pain Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia\u2014Pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Beltr\u00e0, M., Pin, F., Ballar\u00f2, R., Costelli, P., and Penna, F. (2021). Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration. Cells, 10.","DOI":"10.3390\/cells10113150"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2015.11.002","article-title":"Protein breakdown in cancer cachexia","volume":"54","author":"Sandri","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCO.0000000000000048","article-title":"Coming back: Autophagy in cachexia","volume":"17","author":"Penna","year":"2014","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Ragni, M., Fornelli, C., Nisoli, E., and Penna, F. (2022). Amino Acids in Cancer and Cachexia: An Integrated View. Cancers, 14.","DOI":"10.3390\/cancers14225691"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1096\/fj.201801862R","article-title":"Moderate exercise in mice improves cancer plus chemotherapy-induced muscle wasting and mitochondrial alterations","volume":"33","author":"Pin","year":"2019","journal-title":"FASEB J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jgr.2023.06.004","article-title":"Ginsenoside Rg5 promotes muscle regeneration via p38MAPK and Akt\/mTOR signaling","volume":"47","author":"Kim","year":"2023","journal-title":"J. Ginseng Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clnu.2007.03.008","article-title":"Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexia","volume":"26","author":"Thomas","year":"2007","journal-title":"Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nut.2019.03.012","article-title":"Mediators of cachexia in cancer patients","volume":"66","author":"Busquets","year":"2019","journal-title":"Nutrition"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/jcsm.12251","article-title":"Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-na\u00efve pancreatic cancer patients","volume":"9","author":"Talbert","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","article-title":"Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning","volume":"17","author":"Han","year":"2018","journal-title":"Lipids Health Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jcsm.12626","article-title":"High levels of modified ceramides are a defining feature of murine and human cancer cachexia","volume":"11","author":"Morigny","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcsm.12027","article-title":"Collagen fragment biomarkers as serological biomarkers of lean body mass\u2014A biomarker pilot study from the DAHANCA25B cohort and matched controls","volume":"6","author":"Nedergaard","year":"2015","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Donzelli, S., Farneti, A., Marucci, L., Ganci, F., Sacconi, A., Strano, S., Sanguineti, G., and Blandino, G. (2020). Non-coding RNAs as Putative Biomarkers of Cancer-Associated Cachexia. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00257"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Cao, Z., Zhao, K., Jose, I., Hoogenraad, N.J., and Osellame, L.D. (2021). Biomarkers for Cancer Cachexia: A Mini Review. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094501"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.clinbiochem.2017.07.011","article-title":"Biomarkers of cancer cachexia","volume":"50","author":"Loumaye","year":"2017","journal-title":"Clin. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3892\/ol.2016.5183","article-title":"Growth differentiating factor-15 (GDF-15): A potential biomarker and therapeutic target for cancer-associated weight loss","volume":"12","author":"Lerner","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/fcp.12931","article-title":"Deliberation on debilitating condition of cancer cachexia: Skeletal muscle wasting","volume":"37","author":"Dave","year":"2023","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1002\/ptr.7811","article-title":"Cucurbitacin IIb attenuates cancer cachexia induced skeletal muscle atrophy by regulating the IL-6\/STAT3\/FoxO signaling pathway","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"110847","DOI":"10.1016\/j.cellsig.2023.110847","article-title":"Cancer Cachexia and breast cancer stem cell signalling\u2014A crosstalk of signalling molecules","volume":"110","author":"Shivnani","year":"2023","journal-title":"Cell. Signal."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e57695","DOI":"10.15252\/embr.202357695","article-title":"Convergent Insulin and TGF-\u03b2 signalling drives cancer cachexia by promoting aberrant fatbody ECM accumulation in a Drosophila tumour model","volume":"24","author":"Bakopoulos","year":"2023","journal-title":"EMBO Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"118392","DOI":"10.1016\/j.lfs.2020.118392","article-title":"Exercise training delays cardiac remodeling in a mouse model of cancer cachexia","volume":"260","author":"Fernandes","year":"2020","journal-title":"Life Sci."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Greco, S.H., Tomk\u00f6tter, L., Vahle, A.K., Rokosh, R., Avanzi, A., Mahmood, S.K., Deutsch, M., Alothman, S., Alqunaibit, D., and Ochi, A. (2015). TGF-\u03b2 Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132786"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jcsm.12331","article-title":"LY2495655, an antimyostatin antibody, in pancreatic cancer: A randomized, phase 2 trial","volume":"9","author":"Golan","year":"2018","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Cheng, Q.Q., Mao, S.L., Yang, L.N., Chen, L., Zhu, J.Z., Liu, X., Hou, A.J., and Zhang, R.R. (2023). Fuzheng Xiaoai Decoction 1 ameliorated cancer cachexia-induced muscle atrophy via Akt-mTOR pathway. J. Ethnopharmacol., 303.","DOI":"10.1016\/j.jep.2022.115944"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ahmad, S.S., Ahmad, K., Shaikh, S., You, H.J., Lee, E.Y., Ali, S., Lee, E.J., and Choi, I. (2022). Molecular Mechanisms and Current Treatment Options for Cancer Cachexia. Cancers, 14.","DOI":"10.3390\/cancers14092107"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","article-title":"The role of myostatin in muscle wasting: An overview","volume":"2","author":"Elkina","year":"2011","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"R674","DOI":"10.1152\/ajpregu.00104.2006","article-title":"IGF-1 is downregulated in experimental cancer cachexia","volume":"291","author":"Costelli","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Laudato, J., Tice, A., Rossetti, M., and Steiner, J. (2021). Alcohol Worsens Cancer Cachexia and Anabolic Signaling in C26 Tumor Bearing Mice. FASEB J., 35.","DOI":"10.1096\/fasebj.2021.35.S1.02995"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3389\/fphys.2020.00445","article-title":"Cancer Cachexia Induces Preferential Skeletal Muscle Myosin Loss When Combined with Denervation","volume":"11","author":"Yamada","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1038\/ng.2772","article-title":"BMP signaling controls muscle mass","volume":"45","author":"Sartori","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cytogfr.2020.09.003","article-title":"Receptor binding competition: A paradigm for regulating TGF-\u03b2 family action","volume":"57","author":"Sundan","year":"2021","journal-title":"Cytokine Growth Factor. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jmcb\/mjy036","article-title":"Muscle RING-finger protein-1 (MuRF1) functions and cellular localization are regulated by SUMO1 post-translational modification","volume":"11","author":"Heras","year":"2019","journal-title":"J. Mol. Cell Biol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Rao, V.K., Das, D., and Taneja, R. (2022). Cancer Cachexia: Signaling and Transcriptional Regulation of Muscle Catabolic Genes. Cancers, 14.","DOI":"10.3390\/cancers14174258"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1097-2765(04)00211-4","article-title":"The IGF-1\/PI3K\/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors","volume":"14","author":"Stitt","year":"2004","journal-title":"Mol. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/sj.cgt.7701091","article-title":"Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice","volume":"14","author":"Liu","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.201001136","article-title":"JunB transcription factor maintains skeletal muscle mass and promotes hypertrophy","volume":"191","author":"Raffaello","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Chong, S.W., Nguyet, L.M., Jiang, Y.J., and Korzh, V. (2007). The chemokine Sdf-1 and its receptor Cxcr4 are required for formation of muscle in zebrafish. BMC Dev. Biol., 7.","DOI":"10.1186\/1471-213X-7-54"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/onc.2016.153","article-title":"Activation of the SDF1\/CXCR4 pathway retards muscle atrophy during cancer cachexia","volume":"35","author":"Martinelli","year":"2016","journal-title":"Oncogene"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"C1258","DOI":"10.1152\/ajpcell.00105.2009","article-title":"Myostatin reduces Akt\/TORC1\/p70S6K signaling, inhibiting myoblast differentiation and myotube size","volume":"296","author":"Trendelenburg","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"C1124","DOI":"10.1152\/ajpcell.00043.2009","article-title":"Myostatin inhibits IGF-I-induced myotube hypertrophy through Akt","volume":"297","author":"Morissette","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semcancer.2016.01.002","article-title":"F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities","volume":"36","author":"Sukari","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Alves, M.J., Figuer\u00eado, R.G., Azevedo, F.F., Cavallaro, D.A., Neto, N.I., Lima, J.D., Matos-Neto, E., Radloff, K., Riccardi, D.M., and Camargo, R.G. (2017). Adipose tissue fibrosis in human cancer cachexia: The role of TGF\u03b2 pathway. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3178-8"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcvm.2018.00069","article-title":"Kr\u00fcppel-like Factors in Metabolic Homeostasis and Cardiometabolic Disease","volume":"5","author":"Oishi","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kammoun, M., Pouletaut, P., Canon, F., Subramaniam, M., Hawse, J.R., Vayssade, M., and Bensamoun, S.F. (2016). Impact of TIEG1 Deletion on the Passive Mechanical Properties of Fast and Slow Twitch Skeletal Muscles in Female Mice. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164566"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"13876","DOI":"10.1074\/jbc.M113.457648","article-title":"Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein","volume":"288","author":"Parakati","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e2215095120","DOI":"10.1073\/pnas.2215095120","article-title":"A TGF-\u03b2\/KLF10 signaling axis regulates atrophy-associated genes to induce muscle wasting in pancreatic cancer","volume":"120","author":"Dasgupta","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2044-5040-2-3","article-title":"TAK-1\/p38\/nNF\u03baB signaling inhibits myoblast differentiation by increasing levels of Activin A","volume":"2","author":"Trendelenburg","year":"2012","journal-title":"Skelet. Muscle"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","article-title":"TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications","volume":"170","author":"Patel","year":"2017","journal-title":"Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ejhf.2840","article-title":"The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia","volume":"25","author":"Poetsch","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_73","first-page":"1913","article-title":"Metabolic signatures and potential biomarkers for the diagnosis and treatment of colon cancer cachexia","volume":"55","author":"Qiu","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diabetes.51.5.1319","article-title":"Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: Nuclear factor-kappaB activation by TNF-alpha is obligatory","volume":"51","author":"Ruan","year":"2002","journal-title":"Diabetes"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/s41467-022-29752-0","article-title":"Supraphysiological activation of TAK1 promotes skeletal muscle growth and mitigates neurogenic atrophy","volume":"13","author":"Roy","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/jcsm.13246","article-title":"Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia","volume":"14","author":"Dolly","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Zeng, R., Tong, C., and Xiong, X. (2022). The Molecular Basis and Therapeutic Potential of Leukemia Inhibitory Factor in Cancer Cachexia. Cancers, 14.","DOI":"10.3390\/cancers14122955"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"eaay9592","DOI":"10.1126\/scitranslmed.aay9592","article-title":"Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia","volume":"13","author":"Sartori","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1083\/jcb.201211134","article-title":"The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass","volume":"203","author":"Winbanks","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1475-097X.1983.tb00847.x","article-title":"Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia","volume":"3","author":"Rennie","year":"1983","journal-title":"Clin. Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bmj.289.6445.584","article-title":"Protein synthesis in muscle measured in vivo in cachectic patients with cancer","volume":"289","author":"Emery","year":"1984","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1152\/japplphysiol.00536.2021","article-title":"REDD1 deletion attenuates cancer cachexia in mice","volume":"131","author":"Hain","year":"2021","journal-title":"J. Appl. Physiol."},{"key":"ref_83","first-page":"e21335","article-title":"Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia","volume":"35","author":"Kim","year":"2021","journal-title":"FASEB J."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1152\/japplphysiol.00246.2022","article-title":"LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting","volume":"133","author":"Belcher","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aar2663","article-title":"NUFIP1 is a ribosome receptor for starvation-induced ribophagy","volume":"360","author":"Wyant","year":"2018","journal-title":"Science"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2015.1100356","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)","volume":"12","author":"Klionsky","year":"2016","journal-title":"Autophagy"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.3892\/mmr.2020.11608","article-title":"Molecular mechanisms of cancer cachexia-induced muscle atrophy (Review)","volume":"22","author":"Yang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Khan, B., Gand, L.V., Amrute-Nayak, M., and Nayak, A. (2023). Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective. Cells, 12.","DOI":"10.3390\/cells12040644"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/med.20010","article-title":"Cross-talk between skeletal muscle and adipose tissue: A link with obesity?","volume":"25","author":"Almendro","year":"2005","journal-title":"Med. Res. Rev."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11684-017-0555-2","article-title":"Role of brown adipose tissue in metabolic syndrome, aging, and cancer cachexia","volume":"12","author":"Dong","year":"2018","journal-title":"Front. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"848394","DOI":"10.3389\/fonc.2022.848394","article-title":"Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia","volume":"12","author":"Weber","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e20190450","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"218","author":"Rupert","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"C1624","DOI":"10.1152\/ajpcell.00424.2022","article-title":"Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia","volume":"323","author":"Uddin","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"101101","DOI":"10.1016\/j.tranon.2021.101101","article-title":"Non-coding RNAs in cancer-associated cachexia: Clinical implications and future perspectives","volume":"14","author":"Kottorou","year":"2021","journal-title":"Transl. Oncol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"367561","DOI":"10.1155\/2015\/367561","article-title":"Cancer Cachexia and MicroRNAs","volume":"2015","author":"Camargo","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1152\/physrev.00006.2010","article-title":"MicroRNAs in development and disease","volume":"91","author":"Sayed","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cmet.2006.05.009","article-title":"MicroRNAs: A new class of regulatory genes affecting metabolism","volume":"4","author":"Stoffel","year":"2006","journal-title":"Cell Metab."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Homa-Mlak, I., Pigo\u0144-Zaj\u0105c, D., Wawrejko, P., Ma\u0142ecka-Massalska, T., and Mlak, R. (2022). Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass\u2014The Role of miRNAs. J. Pers. Med., 12.","DOI":"10.3390\/jpm12091438"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jcsm.13224","article-title":"Specific miRNAs are associated with human cancer cachexia in an organ-specific manner","volume":"14","author":"Krauss","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/jcsm.12512","article-title":"Identification of microRNAs in skeletal muscle associated with lung cancer cachexia","volume":"11","author":"Schols","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"E267","DOI":"10.1152\/ajpendo.00249.2013","article-title":"MicroRNA profiling links miR-378 to enhanced adipocyte lipolysis in human cancer cachexia","volume":"306","author":"Gao","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood-2004-10-3819","article-title":"c-Jun N-terminal kinase (JNK) is required for survival and proliferation of B-lymphoma cells","volume":"106","author":"Gururajan","year":"2005","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/ncb0203-87","article-title":"Signalling pathways that mediate skeletal muscle hypertrophy and atrophy","volume":"5","author":"Glass","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(02)00006-X","article-title":"Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress","volume":"180","author":"Tisdale","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1126\/science.1065874","article-title":"Identification of ubiquitin ligases required for skeletal muscle atrophy","volume":"294","author":"Bodine","year":"2001","journal-title":"Science"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/1535-7163.MCT-16-0324","article-title":"Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation","volume":"16","author":"Yan","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1096\/fj.04-2364com","article-title":"TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1\/MAFbx in skeletal muscle","volume":"19","author":"Li","year":"2005","journal-title":"FASEB J."},{"key":"ref_111","first-page":"92","article-title":"JNK and NFAT: Key players in the development of cancer cachexia?","volume":"28","author":"Assi","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2020.07.025","article-title":"JNK signaling contributes to skeletal muscle wasting and protein turnover in pancreatic cancer cachexia","volume":"491","author":"Mulder","year":"2020","journal-title":"Cancer Lett."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.neo.2021.11.008","article-title":"Amelioration of muscle wasting by gintonin in cancer cachexia","volume":"23","author":"Wijaya","year":"2021","journal-title":"Neoplasia"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"665493","DOI":"10.3389\/fphar.2021.665493","article-title":"Nicotinamide Riboside Vitamin B3 Mitigated C26 Adenocarcinoma\u2013Induced Cancer Cachexia","volume":"12","author":"Park","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/acel.12342","article-title":"Longevity and skeletal muscle mass: The role of IGF signalling, the sirtuins, dietary restriction and protein intake","volume":"14","author":"Sharples","year":"2015","journal-title":"Aging Cell"},{"key":"ref_117","first-page":"292","article-title":"Loss of FOXOs in skeletal muscle prevents the onset of cancer cachexia-induced muscle atrophy","volume":"79","author":"Oyabu","year":"2023","journal-title":"Ann. Nutr. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e20190745","DOI":"10.1084\/jem.20190745","article-title":"SIRT1-NOX4 signaling axis regulates cancer cachexia","volume":"217","author":"Dasgupta","year":"2020","journal-title":"J. Exp. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2005.08.011","article-title":"Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses","volume":"123","author":"Chen","year":"2005","journal-title":"Cell"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrc3800","article-title":"The impact of the endoplasmic reticulum protein-folding environment on cancer development","volume":"14","author":"Wang","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/sj.cdd.4401840","article-title":"From acute ER stress to physiological roles of the Unfolded Protein Response","volume":"13","author":"Wu","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: Controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e00184-19","DOI":"10.1128\/MCB.00184-19","article-title":"The Toll-like Receptor\/MyD88\/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia","volume":"39","author":"Bohnert","year":"2019","journal-title":"Mol. Cell Biol."},{"key":"ref_124","first-page":"160","article-title":"TIR-domain-containing adapter-inducing interferon-\u03b2 (TRIF) signaling is important in acute illness response and cancer cachexia","volume":"8","author":"Burfeind","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbi.2018.05.021","article-title":"TRIF is a key inflammatory mediator of acute sickness behavior and cancer cachexia","volume":"73","author":"Burfeind","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/s41467-017-01866-w","article-title":"MyD88 promotes myoblast fusion in a cell-autonomous manner","volume":"8","author":"Hindi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/path.4714","article-title":"Toll-like receptor signalling in regenerative myogenesis: Friend and foe","volume":"239","author":"Hindi","year":"2016","journal-title":"J. Pathol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1096\/fj.201600250RR","article-title":"Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia","volume":"30","author":"Bohnert","year":"2016","journal-title":"FASEB J."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ni.1857","article-title":"TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages","volume":"11","author":"Martinon","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.molcel.2007.06.011","article-title":"XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks","volume":"27","author":"Zhou","year":"2007","journal-title":"Mol. Cell"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/jcsm.12377","article-title":"MyD88 signalling is critical in the development of pancreatic cancer cachexia","volume":"10","author":"Zhu","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2015.10.038","article-title":"The central role of hypothalamic inflammation in the acute illness response and cachexia","volume":"54","author":"Burfeind","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1128\/IAI.00890-12","article-title":"TRIF mediates Toll-like receptor 2-dependent inflammatory responses to Borrelia burgdorferi","volume":"81","author":"Chung","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1074\/jbc.M114.593426","article-title":"A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling","volume":"290","author":"Nilsen","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1742-2094-9-46","article-title":"Heme activates TLR4-mediated inflammatory injury via MyD88\/TRIF signaling pathway in intracerebral hemorrhage","volume":"9","author":"Lin","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fonc.2020.00298","article-title":"Management of Cancer Cachexia: Attempting to Develop New Pharmacological Agents for New Effective Therapeutic Options","volume":"10","author":"Marceca","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Directo, D., and Lee, S.R. (2023). Cancer Cachexia: Underlying Mechanisms and Potential Therapeutic Interventions. Metabolites, 13.","DOI":"10.3390\/metabo13091024"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Liu, Y., Dantas, E., Ferrer, M., Liu, Y., Comjean, A., Davidson, E.E., Hu, Y., Goncalves, M.D., Janowitz, T., and Perrimon, N. (2023). Tumor Cytokine-Induced Hepatic Gluconeogenesis Contributes to Cancer Cachexia: Insights from Full Body Single Nuclei Sequencing. bioRxiv.","DOI":"10.1101\/2023.05.15.540823"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4240\/wjgs.v10.i9.95","article-title":"Molecular therapeutic strategies targeting pancreatic cancer induced cachexia","volume":"10","author":"Yakovenko","year":"2018","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"aa72","DOI":"10.1093\/annonc\/mdz155.263","article-title":"Chinese herbal medicine Sijunzi decoction alleviates liver cancer cachexia through downregulating TGF-\u03b2 and IGF 1 signaling pathways","volume":"30","author":"Chen","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-12-385961-7.00013-5","article-title":"The regulation and functions of activin and follistatin in inflammation and immunity","volume":"85","author":"Hedger","year":"2011","journal-title":"Vitam. Horm."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"103749","DOI":"10.1016\/j.critrevonc.2022.103749","article-title":"Prospects of targeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"176","author":"Mortazavi","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Cao, Z., Jose, I., Glab, J., Puthalakath, H., Osellame, L.D., and Hoogenraad, N.J. (2020). Generation of reporter cell lines for factors inducing muscle wasting in cancer cachexia. Anal. Biochem., 606.","DOI":"10.1016\/j.ab.2020.113877"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s00520-015-2892-5","article-title":"Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1\/Akt and autophagy signal in cancer cachexia","volume":"24","author":"Zhuang","year":"2016","journal-title":"Support. Care Cancer"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Aquila, G., Re Cecconi, A.D., Brault, J.J., Corli, O., and Piccirillo, R. (2020). Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia. Cells, 9.","DOI":"10.3390\/cells9122536"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12943-015-0291-7","article-title":"The role of the insulin-like growth factor-1 system in breast cancer","volume":"14","author":"Christopoulos","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jpen.2287","article-title":"Nutrition challenges of cancer cachexia","volume":"45","author":"Gaafer","year":"2021","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"dmm043166","DOI":"10.1242\/dmm.043166","article-title":"HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia","volume":"13","author":"Huot","year":"2020","journal-title":"DMM Dis. Models Mech."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"109326","DOI":"10.1016\/j.mehy.2019.109326","article-title":"Nutraceutical targeting of TLR4 signaling has potential for prevention of cancer cachexia","volume":"132","author":"McCarty","year":"2019","journal-title":"Med. Hypotheses"},{"key":"ref_152","first-page":"178","article-title":"The quest for a novel biomarker for cancer cachexia: Rational and design for a case control study","volume":"8","author":"Aboda","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/3\/252\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:21Z","timestamp":1760104281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/3\/252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":152,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["cells13030252"],"URL":"https:\/\/doi.org\/10.3390\/cells13030252","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,29]]}}}